IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 275 filers reported holding IMMUNOGEN INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $388,531,801 | -1.5% | 24,482,155 | +17.1% | 0.01% | +11.1% |
| Q2 2023 | $394,364,621 | +586.1% | 20,899,026 | +39.6% | 0.01% | +800.0% |
| Q1 2023 | $57,478,356 | -19.4% | 14,968,322 | +4.1% | 0.00% | -50.0% |
| Q4 2022 | $71,317,038 | -4.5% | 14,378,435 | -8.0% | 0.00% | 0.0% |
| Q3 2022 | $74,687,000 | +3.4% | 15,624,848 | -2.7% | 0.00% | 0.0% |
| Q2 2022 | $72,266,000 | -1.9% | 16,059,020 | +3.8% | 0.00% | 0.0% |
| Q1 2022 | $73,678,000 | -34.4% | 15,478,516 | +2.3% | 0.00% | -33.3% |
| Q4 2021 | $112,278,000 | +35.5% | 15,131,752 | +3.6% | 0.00% | +50.0% |
| Q3 2021 | $82,847,000 | -14.2% | 14,611,623 | -0.3% | 0.00% | 0.0% |
| Q2 2021 | $96,565,000 | -16.7% | 14,653,190 | +2.4% | 0.00% | -33.3% |
| Q1 2021 | $115,886,000 | +26.9% | 14,307,139 | +1.1% | 0.00% | 0.0% |
| Q4 2020 | $91,313,000 | +78.8% | 14,157,000 | -0.2% | 0.00% | +50.0% |
| Q3 2020 | $51,080,000 | -25.5% | 14,188,530 | -4.8% | 0.00% | 0.0% |
| Q2 2020 | $68,563,000 | +25.3% | 14,904,994 | -7.1% | 0.00% | 0.0% |
| Q1 2020 | $54,707,000 | -24.7% | 16,042,784 | +12.8% | 0.00% | 0.0% |
| Q4 2019 | $72,622,000 | +115.3% | 14,225,670 | +2.1% | 0.00% | +100.0% |
| Q3 2019 | $33,733,000 | +45.8% | 13,939,556 | +30.8% | 0.00% | 0.0% |
| Q2 2019 | $23,131,000 | -18.9% | 10,659,479 | +1.2% | 0.00% | 0.0% |
| Q1 2019 | $28,534,000 | -43.3% | 10,529,150 | +0.4% | 0.00% | -50.0% |
| Q4 2018 | $50,362,000 | -47.6% | 10,492,223 | +3.3% | 0.00% | -50.0% |
| Q3 2018 | $96,201,000 | +1.2% | 10,158,434 | +4.0% | 0.00% | 0.0% |
| Q2 2018 | $95,038,000 | +1.6% | 9,767,517 | +9.9% | 0.00% | 0.0% |
| Q1 2018 | $93,507,000 | +51.1% | 8,888,608 | -7.9% | 0.00% | +33.3% |
| Q4 2017 | $61,892,000 | +11.1% | 9,655,527 | +32.6% | 0.00% | 0.0% |
| Q3 2017 | $55,686,000 | +84.3% | 7,279,254 | +71.3% | 0.00% | +200.0% |
| Q2 2017 | $30,209,000 | +89.9% | 4,248,688 | +3.4% | 0.00% | 0.0% |
| Q1 2017 | $15,907,000 | +90.9% | 4,110,431 | +0.7% | 0.00% | – |
| Q4 2016 | $8,331,000 | -47.3% | 4,083,290 | -30.7% | 0.00% | -100.0% |
| Q3 2016 | $15,802,000 | -26.9% | 5,896,321 | -16.0% | 0.00% | 0.0% |
| Q2 2016 | $21,615,000 | -62.2% | 7,017,710 | +4.6% | 0.00% | -75.0% |
| Q1 2016 | $57,159,000 | -34.0% | 6,708,705 | +5.1% | 0.00% | -33.3% |
| Q4 2015 | $86,650,000 | -71.8% | 6,385,382 | -64.8% | 0.01% | -45.5% |
| Q3 2015 | $306,857,000 | +272.8% | 18,141,474 | +216.9% | 0.01% | +83.3% |
| Q2 2015 | $82,314,000 | +64.9% | 5,724,157 | +2.6% | 0.01% | +100.0% |
| Q1 2015 | $49,929,000 | +54.1% | 5,578,691 | +5.1% | 0.00% | +50.0% |
| Q4 2014 | $32,392,000 | -40.9% | 5,310,180 | +2.6% | 0.00% | -50.0% |
| Q3 2014 | $54,805,000 | -11.1% | 5,175,126 | -0.5% | 0.00% | -20.0% |
| Q2 2014 | $61,641,000 | -21.3% | 5,201,812 | -0.8% | 0.01% | -28.6% |
| Q1 2014 | $78,286,000 | +5.8% | 5,243,545 | +4.0% | 0.01% | 0.0% |
| Q4 2013 | $73,963,000 | -10.1% | 5,041,738 | +4.3% | 0.01% | -12.5% |
| Q3 2013 | $82,236,000 | +6.0% | 4,831,726 | +3.3% | 0.01% | 0.0% |
| Q2 2013 | $77,567,000 | – | 4,675,560 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |